cerrar
Tagged with USA,

Can the USA’s Fragmented Healthcare System Become More…
US healthcare is often seen as a fragmented system of contrasts. The country has the highest healthcare expenditures as a percentage of GDP and the…

Forging Connections & Trust – At A Safe Social…
Takeda’s Head of R&D Patient Engagement Jessica Scott examines the parallels between partnering with patients and working remotely with…

Marc Boutin – CEO, National Health Council, USA
Marc Boutin, JD, CEO of the National Health Council (NHC),* introduces the organization and its mission to provide a united voice for the 160 million…

Robert Matsuk – President, Glenmark North America
Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US - including a manufacturing facility…

Biocon’s Recipe for Success in the Competitive US Generics…
Indian firm Biocon has seen great success in the US in recent years, with two biosimilar launches and a range of generic medicines now available on…

Why Technology Is Key To Surviving COVID-19
Sophia Ononye-Onyia outlines the key failings in the USA’s response to the coronavirus outbreak and why greater numbers of inter-industry…

KV Kumar – President & CEO, Indian American…
KV Kumar, head of the Indian American International Chamber of Commerce, gives an account of the bilateral trade relations between India and the US…

Abhijit Zutshi – Commercial Head Global Generics & SVP…
Abhijit Zutshi, commercial head global generics & SVP marketing at Indian firm Biocon highlights the challenges inherent in the US generics…

Dan Leonard – President & CEO, National Pharmaceutical…
Dan Leonard is president & CEO of the National Pharmaceutical Council, which sponsors and participates in research on the appropriate use of…

“Drug” Companies are Missing Their Moment to Write a New…
John G. Singer examines how the ongoing coronavirus pandemic may create a new dichotomy for global healthcare - and why pharma companies still wedded…

How US Generics Firms are Responding to COVID-19 Supply Chain…
AAM Interim President Jeff Francer outlines the vital role that biosimilar and generics firms will play in filling supply chain gaps during the…

First Antibiotic Discovered Using Artificial Intelligence
Artificial intelligence (AI) is increasingly being utilised in the drug discovery process, with the latest breakthrough being the development of an…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here